aluates Reports

$ 0.0

Automative

Global Durvalumab Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-30C9391

Global Durvalumab Market Insights and Forecast to 2028

BUY CHAPTERS

Global Durvalumab Market Research Report 2025

Code: QYRE-Auto-30C9391

Report

September 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

MedImmune/AstraZeneca

Durvalumab Market

The global market for Durvalumab was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Durvalumab is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Durvalumab is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Durvalumab include Medimmune (AstraZeneca), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Durvalumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Durvalumab.

The Durvalumab market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Durvalumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Durvalumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Durvalumab Market Report

Report Metric	Details
Report Name	Durvalumab Market
Segment by Type	2.4mL Injection 10mL Injection
Segment by Application	Locally Advanced Urothelial Carcinoma Metastatic Urothelial Carcinoma Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medimmune (AstraZeneca)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Durvalumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Durvalumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Durvalumab Market report?

Ans: The main players in the Durvalumab Market are Medimmune (AstraZeneca)

What are the Application segmentation covered in the Durvalumab Market report?

Ans: The Applications covered in the Durvalumab Market report are Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Others

What are the Type segmentation covered in the Durvalumab Market report?

Ans: The Types covered in the Durvalumab Market report are 2.4mL Injection, 10mL Injection

1 Durvalumab Market Overview

1.1 Product Definition

1.2 Durvalumab by Type

1.2.1 Global Durvalumab Market Value Comparison by Type (2024 VS 2031)

1.2.2 2.4mL Injection

1.2.3 10mL Injection

1.3 Durvalumab by Application

1.3.1 Global Durvalumab Market Value by Application (2024 VS 2031)

1.3.2 Locally Advanced Urothelial Carcinoma

1.3.3 Metastatic Urothelial Carcinoma

1.3.4 Others

1.4 Global Durvalumab Market Size Estimates and Forecasts

1.4.1 Global Durvalumab Revenue 2020-2031

1.4.2 Global Durvalumab Sales 2020-2031

1.4.3 Global Durvalumab Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Durvalumab Market Competition by Manufacturers

2.1 Global Durvalumab Sales Market Share by Manufacturers (2020-2025)

2.2 Global Durvalumab Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Durvalumab Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Durvalumab, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Durvalumab, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Durvalumab, Product Type & Application

2.7 Global Key Manufacturers of Durvalumab, Date of Enter into This Industry

2.8 Global Durvalumab Market Competitive Situation and Trends

2.8.1 Global Durvalumab Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Durvalumab Players Market Share by Revenue

2.8.3 Global Durvalumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Durvalumab Market Scenario by Region

3.1 Global Durvalumab Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Durvalumab Sales by Region: 2020-2031

3.2.1 Global Durvalumab Sales by Region: 2020-2025

3.2.2 Global Durvalumab Sales by Region: 2026-2031

3.3 Global Durvalumab Revenue by Region: 2020-2031

3.3.1 Global Durvalumab Revenue by Region: 2020-2025

3.3.2 Global Durvalumab Revenue by Region: 2026-2031

3.4 North America Durvalumab Market Facts & Figures by Country

3.4.1 North America Durvalumab Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Durvalumab Sales by Country (2020-2031)

3.4.3 North America Durvalumab Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Durvalumab Market Facts & Figures by Country

3.5.1 Europe Durvalumab Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Durvalumab Sales by Country (2020-2031)

3.5.3 Europe Durvalumab Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Durvalumab Market Facts & Figures by Region

3.6.1 Asia Pacific Durvalumab Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Durvalumab Sales by Region (2020-2031)

3.6.3 Asia Pacific Durvalumab Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Durvalumab Market Facts & Figures by Country

3.7.1 Latin America Durvalumab Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Durvalumab Sales by Country (2020-2031)

3.7.3 Latin America Durvalumab Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Durvalumab Market Facts & Figures by Country

3.8.1 Middle East and Africa Durvalumab Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Durvalumab Sales by Country (2020-2031)

3.8.3 Middle East and Africa Durvalumab Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Durvalumab Sales by Type (2020-2031)

4.1.1 Global Durvalumab Sales by Type (2020-2025)

4.1.2 Global Durvalumab Sales by Type (2026-2031)

4.1.3 Global Durvalumab Sales Market Share by Type (2020-2031)

4.2 Global Durvalumab Revenue by Type (2020-2031)

4.2.1 Global Durvalumab Revenue by Type (2020-2025)

4.2.2 Global Durvalumab Revenue by Type (2026-2031)

4.2.3 Global Durvalumab Revenue Market Share by Type (2020-2031)

4.3 Global Durvalumab Price by Type (2020-2031)

5 Segment by Application

5.1 Global Durvalumab Sales by Application (2020-2031)

5.1.1 Global Durvalumab Sales by Application (2020-2025)

5.1.2 Global Durvalumab Sales by Application (2026-2031)

5.1.3 Global Durvalumab Sales Market Share by Application (2020-2031)

5.2 Global Durvalumab Revenue by Application (2020-2031)

5.2.1 Global Durvalumab Revenue by Application (2020-2025)

5.2.2 Global Durvalumab Revenue by Application (2026-2031)

5.2.3 Global Durvalumab Revenue Market Share by Application (2020-2031)

5.3 Global Durvalumab Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Medimmune (AstraZeneca)

6.1.1 Medimmune (AstraZeneca) Company Information

6.1.2 Medimmune (AstraZeneca) Description and Business Overview

6.1.3 Medimmune (AstraZeneca) Durvalumab Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Medimmune (AstraZeneca) Durvalumab Product Portfolio

6.1.5 Medimmune (AstraZeneca) Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Durvalumab Industry Chain Analysis

7.2 Durvalumab Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Durvalumab Production Mode & Process Analysis

7.4 Durvalumab Sales and Marketing

7.4.1 Durvalumab Sales Channels

7.4.2 Durvalumab Distributors

7.5 Durvalumab Customer Analysis

8 Durvalumab Market Dynamics

8.1 Durvalumab Industry Trends

8.2 Durvalumab Market Drivers

8.3 Durvalumab Market Challenges

8.4 Durvalumab Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

MedImmune/AstraZeneca

List of Tables

Table 1. Global Durvalumab Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Durvalumab Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Durvalumab Market Competitive Situation by Manufacturers in 2024

Table 4. Global Durvalumab Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Durvalumab Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Durvalumab Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Durvalumab Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Durvalumab Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Durvalumab, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Durvalumab, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Durvalumab, Product Type & Application

Table 12. Global Key Manufacturers of Durvalumab, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Durvalumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Durvalumab as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Durvalumab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Durvalumab Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Durvalumab Sales Market Share by Region (2020-2025)

Table 19. Global Durvalumab Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Durvalumab Sales Market Share by Region (2026-2031)

Table 21. Global Durvalumab Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Durvalumab Revenue Market Share by Region (2020-2025)

Table 23. Global Durvalumab Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Durvalumab Revenue Market Share by Region (2026-2031)

Table 25. North America Durvalumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Durvalumab Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Durvalumab Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Durvalumab Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Durvalumab Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Durvalumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Durvalumab Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Durvalumab Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Durvalumab Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Durvalumab Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Durvalumab Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Durvalumab Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Durvalumab Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Durvalumab Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Durvalumab Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Durvalumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Durvalumab Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Durvalumab Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Durvalumab Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Durvalumab Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Durvalumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Durvalumab Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Durvalumab Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Durvalumab Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Durvalumab Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Durvalumab Sales (K Pcs) by Type (2020-2025)

Table 51. Global Durvalumab Sales (K Pcs) by Type (2026-2031)

Table 52. Global Durvalumab Sales Market Share by Type (2020-2025)

Table 53. Global Durvalumab Sales Market Share by Type (2026-2031)

Table 54. Global Durvalumab Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Durvalumab Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Durvalumab Revenue Market Share by Type (2020-2025)

Table 57. Global Durvalumab Revenue Market Share by Type (2026-2031)

Table 58. Global Durvalumab Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Durvalumab Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Durvalumab Sales (K Pcs) by Application (2020-2025)

Table 61. Global Durvalumab Sales (K Pcs) by Application (2026-2031)

Table 62. Global Durvalumab Sales Market Share by Application (2020-2025)

Table 63. Global Durvalumab Sales Market Share by Application (2026-2031)

Table 64. Global Durvalumab Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Durvalumab Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Durvalumab Revenue Market Share by Application (2020-2025)

Table 67. Global Durvalumab Revenue Market Share by Application (2026-2031)

Table 68. Global Durvalumab Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Durvalumab Price (USD/Pcs) by Application (2026-2031)

Table 70. Medimmune (AstraZeneca) Company Information

Table 71. Medimmune (AstraZeneca) Description and Business Overview

Table 72. Medimmune (AstraZeneca) Durvalumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Medimmune (AstraZeneca) Durvalumab Product

Table 74. Medimmune (AstraZeneca) Recent Developments/Updates

Table 75. Key Raw Materials Lists

Table 76. Raw Materials Key Suppliers Lists

Table 77. Durvalumab Distributors List

Table 78. Durvalumab Customers List

Table 79. Durvalumab Market Trends

Table 80. Durvalumab Market Drivers

Table 81. Durvalumab Market Challenges

Table 82. Durvalumab Market Restraints

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

Table 86. Authors List of This Report

List of Figures

Figure 1. Product Picture of Durvalumab

Figure 2. Global Durvalumab Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Durvalumab Market Share by Type: 2024 & 2031

Figure 4. 2.4mL Injection Product Picture

Figure 5. 10mL Injection Product Picture

Figure 6. Global Durvalumab Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Durvalumab Market Share by Application: 2024 & 2031

Figure 8. Locally Advanced Urothelial Carcinoma

Figure 9. Metastatic Urothelial Carcinoma

Figure 10. Others

Figure 11. Global Durvalumab Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Durvalumab Market Size (2020-2031) & (US$ Million)

Figure 13. Global Durvalumab Sales (2020-2031) & (K Pcs)

Figure 14. Global Durvalumab Average Price (USD/Pcs) & (2020-2031)

Figure 15. Durvalumab Report Years Considered

Figure 16. Durvalumab Sales Share by Manufacturers in 2024

Figure 17. Global Durvalumab Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Durvalumab Players: Market Share by Revenue in Durvalumab in 2024

Figure 19. Durvalumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Durvalumab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Durvalumab Sales Market Share by Country (2020-2031)

Figure 22. North America Durvalumab Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Durvalumab Sales Market Share by Country (2020-2031)

Figure 26. Europe Durvalumab Revenue Market Share by Country (2020-2031)

Figure 27. Germany Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Durvalumab Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Durvalumab Revenue Market Share by Region (2020-2031)

Figure 34. China Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Durvalumab Sales Market Share by Country (2020-2031)

Figure 45. Latin America Durvalumab Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Durvalumab Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Durvalumab Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. U.A.E Durvalumab Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Durvalumab by Type (2020-2031)

Figure 55. Global Revenue Market Share of Durvalumab by Type (2020-2031)

Figure 56. Global Durvalumab Price (USD/Pcs) by Type (2020-2031)

Figure 57. Global Sales Market Share of Durvalumab by Application (2020-2031)

Figure 58. Global Revenue Market Share of Durvalumab by Application (2020-2031)

Figure 59. Global Durvalumab Price (USD/Pcs) by Application (2020-2031)

Figure 60. Durvalumab Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Ramucirumab Market Research Report 2024

Global Elotuzumab Market Research Report 2024

Global Avelumab Market Research Report 2024

Global Burosumab Market Research Report 2025

Global Siltuximab Market Research Report 2024

Global Pembrolizumab Market Research Report 2024

Global Satralizumab Market Research Report 2025

Global Nivolumab Market Research Report 2024

Global Novaluron Market Research Report 2025

Global Amivantamab Market Research Report 2024

Global Durian Market Research Report 2024

Global Tumor Immunity Therapy Market Research Report 2024

Global Vemurafenib Market Research Report 2025

Global Trastuzumab Market Research Report 2025

Global Duloxetine Hydrochloride API Market Research Report 2025

Global Talazoparib Market Research Report 2024

Global Fostamatinib Market Research Report 2024

Global Health Product for Immune Market Research Report 2024

Global Pivampicillin Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19A18322

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3E3525

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35T3049

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33Y1801

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Durvalumab Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-30C9391

Global Durvalumab Market Research Report 2025

FEATURED COMPANIES

Durvalumab Market

Report Scope

Scope of Durvalumab Market Report

Core Chapters

FAQ for this report

Who are the main players in the Durvalumab Market report?

What are the Application segmentation covered in the Durvalumab Market report?

What are the Type segmentation covered in the Durvalumab Market report?

FEATURED COMPANIES

RELATED REPORTS